Essex Bio-Technology Limited, located in Hong Kong, is a bio-pharmaceutical company specializing in the development, manufacturing, and commercialization of genetically engineered therapeutic fibroblast growth factors (FGF). Since 1998, the company has successfully obtained approval for six flagship biologics that cater to a diverse range of indications. Their portfolio of products aims to address commercial and clinical unmet needs in therapeutic areas such as Ophthalmology, Dermatology, and Wound Healing. With a strong presence, their products are available in over 12,100 hospitals, managed directly by their 43 regional sales offices. Additionally, Essex Bio-Technology Limited maintains an extensive pipeline of projects in various clinical stages, utilizing their in-house R&D platform in growth factors and antibodies.
Headquarters
Room 2818, China Merchants Tower, Shun Tak Centre, 168-200 Connaught Road Central
Hong Kong; Hong Kong;
Contact Details: Purchase the Essex Bio-Technology Limited report to view the information.
Website: http://www.essexbio.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service